GE HealthCare Technologies Inc. (GEHC)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for GEHC is $83.63, 20.2% above the last close of $69.57 on Oct 16, 2026; targets range from $66.45 to $105.48. Rating consensus: Buy.
Snapshot
- P/E20.2x
- P/E vs sector-28.4%
- P/E vs own+3.0%
- Target upside+20.2%
- ConsensusBuy
- Market cap$31.42B
- FCF yield+2.8%
- InsidersNone in 90d
- Earnings in12d
- News
Why it moved
GE HealthCare Technologies Inc. (GEHC) fell 1.1% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
1 story on the day (30-day average 0.8).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $69.57 · -5.0% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▼
- Above MAs3 of 4 above
- MA20×50↑ in ~9d
- RSI61
- Support-4.8%
- Resistance+1.5%
- Off 52w high-21.0%
- Off ATH-25.6%
- 52w range$69.57
- Bollingerupper half
- MACD0.70
- ATR+2.5%
- Volume0.8x
Analyst price targets
15 firms with a target in the last 12 months · last close $69.57 · as of Oct 16, 2026
Strong buy 6 · Buy 10 · Hold 5 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +5.8% year over year, free cash flow -11.7% of revenue, operating margin 14.0%.
| Q2 FY2026 | Jun 30, 2026 | $5.29B | 1.24 | -$617M | 41.2% | 14.0% | 10.8% |
| Q1 FY2026 | Mar 31, 2026 | $5.13B | 0.85 | $112M | 38.5% | 10.0% | 7.6% |
| Q4 FY2025 | Dec 31, 2025 | $4.67B | 0.38 | $917M | 54.3% | 14.2% | 3.9% |
| Q3 FY2025 | Sep 30, 2025 | $5.14B | 0.98 | $483M | 38.7% | 12.7% | 8.7% |
| Q2 FY2025 | Jun 30, 2025 | $5.01B | 1.06 | $8M | 39.7% | 13.1% | 9.7% |
| Q1 FY2025 | Mar 31, 2025 | $4.78B | 1.23 | $98M | 42.1% | 13.2% | 11.8% |
| Q4 FY2024 | Dec 31, 2024 | $5.32B | 1.57 | $811M | 42.8% | 15.1% | 13.5% |
| Q3 FY2024 | Sep 30, 2024 | $4.86B | 1.02 | $648M | 41.7% | 13.9% | 9.7% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 2 |  | $44.39 | +0.6% | -57.7% | +50.1% | 18.0 | $64.33B | |
| 3 |  | $86.60 | -1.7% | -9.0% | +15.2% | 49.8 | $49.9B | |
| 4 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 5 | | $69.57 | -1.1% | -21.0% | +20.2% | 20.2 | $31.42B | |
| 6 |  | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | |
| 7 |  | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B | |
| 8 |  | $141.10 | +1.7% | -59.3% | +32.3% | 26.4 | $9.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.